Blocking Btk activity reduces weight loss, increases survival and minimizes morphological changes in IAV infection, suggesting that immunomodulatory treatment targeting Btk is an effective approach for controlling influenza‐induced lung injury.34 The gene discussed is BTK; the disease is influenza.